Epigenetics of cancer-associated muscle catabolism

Ryan M. Carr, Elisa Enriquez-Hesles, Rachel L.O. Olson, Aminah Jatoi, Jason Doles, Martin E Fernandez-Zapico

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Cancer patients are commonly affected by cachexia, a wasting process involving muscle and fat. Specifically, loss of the muscle compartment has been associated with poor prognosis and suboptimal response to therapy. Nutritional support has been ineffective in treating this process leading to investigations into the underlying molecular processes governing muscle catabolism. In this commentary, we discuss the molecular mechanisms of cancer-associated muscle metabolism and the epigenetic processes responsible for the muscle wasting phenotype. Ultimately, we highlight how the epigenome may serve as a promising therapeutic target in reversing cancer-associated muscle catabolism.

Original languageEnglish (US)
Pages (from-to)1259-1265
Number of pages7
JournalEpigenomics
Volume9
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Muscle Neoplasms
Epigenomics
Muscles
Genetic Epigenesis
Cachexia
Nutritional Support
Fats
Phenotype
Therapeutics
Neoplasms

Keywords

  • cachexia
  • cancer
  • epigenetics
  • muscle wasting
  • weight loss

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Epigenetics of cancer-associated muscle catabolism. / Carr, Ryan M.; Enriquez-Hesles, Elisa; Olson, Rachel L.O.; Jatoi, Aminah; Doles, Jason; Fernandez-Zapico, Martin E.

In: Epigenomics, Vol. 9, No. 10, 01.10.2017, p. 1259-1265.

Research output: Contribution to journalReview article

Carr, Ryan M. ; Enriquez-Hesles, Elisa ; Olson, Rachel L.O. ; Jatoi, Aminah ; Doles, Jason ; Fernandez-Zapico, Martin E. / Epigenetics of cancer-associated muscle catabolism. In: Epigenomics. 2017 ; Vol. 9, No. 10. pp. 1259-1265.
@article{f75560a1cc4d4b0fa2e88f87b1244e0c,
title = "Epigenetics of cancer-associated muscle catabolism",
abstract = "Cancer patients are commonly affected by cachexia, a wasting process involving muscle and fat. Specifically, loss of the muscle compartment has been associated with poor prognosis and suboptimal response to therapy. Nutritional support has been ineffective in treating this process leading to investigations into the underlying molecular processes governing muscle catabolism. In this commentary, we discuss the molecular mechanisms of cancer-associated muscle metabolism and the epigenetic processes responsible for the muscle wasting phenotype. Ultimately, we highlight how the epigenome may serve as a promising therapeutic target in reversing cancer-associated muscle catabolism.",
keywords = "cachexia, cancer, epigenetics, muscle wasting, weight loss",
author = "Carr, {Ryan M.} and Elisa Enriquez-Hesles and Olson, {Rachel L.O.} and Aminah Jatoi and Jason Doles and Fernandez-Zapico, {Martin E}",
year = "2017",
month = "10",
day = "1",
doi = "10.2217/epi-2017-0058",
language = "English (US)",
volume = "9",
pages = "1259--1265",
journal = "Epigenomics",
issn = "1750-1911",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Epigenetics of cancer-associated muscle catabolism

AU - Carr, Ryan M.

AU - Enriquez-Hesles, Elisa

AU - Olson, Rachel L.O.

AU - Jatoi, Aminah

AU - Doles, Jason

AU - Fernandez-Zapico, Martin E

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Cancer patients are commonly affected by cachexia, a wasting process involving muscle and fat. Specifically, loss of the muscle compartment has been associated with poor prognosis and suboptimal response to therapy. Nutritional support has been ineffective in treating this process leading to investigations into the underlying molecular processes governing muscle catabolism. In this commentary, we discuss the molecular mechanisms of cancer-associated muscle metabolism and the epigenetic processes responsible for the muscle wasting phenotype. Ultimately, we highlight how the epigenome may serve as a promising therapeutic target in reversing cancer-associated muscle catabolism.

AB - Cancer patients are commonly affected by cachexia, a wasting process involving muscle and fat. Specifically, loss of the muscle compartment has been associated with poor prognosis and suboptimal response to therapy. Nutritional support has been ineffective in treating this process leading to investigations into the underlying molecular processes governing muscle catabolism. In this commentary, we discuss the molecular mechanisms of cancer-associated muscle metabolism and the epigenetic processes responsible for the muscle wasting phenotype. Ultimately, we highlight how the epigenome may serve as a promising therapeutic target in reversing cancer-associated muscle catabolism.

KW - cachexia

KW - cancer

KW - epigenetics

KW - muscle wasting

KW - weight loss

UR - http://www.scopus.com/inward/record.url?scp=85029912378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029912378&partnerID=8YFLogxK

U2 - 10.2217/epi-2017-0058

DO - 10.2217/epi-2017-0058

M3 - Review article

AN - SCOPUS:85029912378

VL - 9

SP - 1259

EP - 1265

JO - Epigenomics

JF - Epigenomics

SN - 1750-1911

IS - 10

ER -